JP2025501461A5 - - Google Patents
Info
- Publication number
- JP2025501461A5 JP2025501461A5 JP2024533998A JP2024533998A JP2025501461A5 JP 2025501461 A5 JP2025501461 A5 JP 2025501461A5 JP 2024533998 A JP2024533998 A JP 2024533998A JP 2024533998 A JP2024533998 A JP 2024533998A JP 2025501461 A5 JP2025501461 A5 JP 2025501461A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- antibody
- bcma
- variable region
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111487287.1 | 2021-12-07 | ||
| CN202111487287.1A CN116284385A (zh) | 2021-12-07 | 2021-12-07 | 靶向bcma的p329g抗体及其与嵌合抗原受体细胞的组合和应用 |
| PCT/CN2022/137266 WO2023104100A1 (zh) | 2021-12-07 | 2022-12-07 | 结合bcma的抗体及其用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025501461A JP2025501461A (ja) | 2025-01-22 |
| JP2025501461A5 true JP2025501461A5 (cg-RX-API-DMAC10.html) | 2025-12-15 |
Family
ID=97567693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024533998A Pending JP2025501461A (ja) | 2021-12-07 | 2022-12-07 | Ｂｃｍａに結合する抗体およびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250034268A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4446341A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2025501461A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20240136952A (cg-RX-API-DMAC10.html) |
| CN (1) | CN118339185A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022405415A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3241912A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023104100A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026158539A1 (zh) * | 2025-01-24 | 2026-07-30 | 信达生物制药(苏州)有限公司 | 靶向cd19，bcma和cd3的三特异性抗体及其用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5336603A (en) | 1987-10-02 | 1994-08-09 | Genentech, Inc. | CD4 adheson variants |
| KR900005995A (ko) | 1988-10-31 | 1990-05-07 | 우메모또 요시마사 | 변형 인터류킨-2 및 그의 제조방법 |
| US5622929A (en) | 1992-01-23 | 1997-04-22 | Bristol-Myers Squibb Company | Thioether conjugates |
| UA112434C2 (uk) | 2011-05-27 | 2016-09-12 | Ґлаксо Ґруп Лімітед | Антигензв'язувальний білок, який специфічно зв'язується з всма |
| CN105384825B (zh) * | 2015-08-11 | 2018-06-01 | 南京传奇生物科技有限公司 | 一种基于单域抗体的双特异性嵌合抗原受体及其应用 |
| EP3572427B1 (en) * | 2017-01-23 | 2025-06-25 | CRAGE medical Co., Limited | Bcma-targeting antibody and use thereof |
| AU2019214183B2 (en) * | 2018-02-01 | 2022-04-07 | Innovent Biologics (Suzhou) Co., Ltd. | Fully human anti-B cell maturation antigen (BCMA) single chain variable fragment, and application thereof |
| WO2020004937A1 (ko) * | 2018-06-26 | 2020-01-02 | 주식회사 티에스디라이프사이언스 | 항-bcma 항체-약물 접합체 및 그 용도 |
| CN109265550B (zh) * | 2018-09-25 | 2020-09-15 | 华东师范大学 | Bcma抗体、嵌合抗原受体和药物 |
| JP2023501871A (ja) * | 2019-09-20 | 2023-01-20 | 上海吉倍生物技術有限公司 | Ｂｃｍａ標的化抗体及びキメラ抗原受容体 |
| WO2021146147A1 (en) * | 2020-01-13 | 2021-07-22 | Nkarta, Inc. | Bcma-directed cellular immunotherapy compositions and methods |
| CN119604525A (zh) * | 2022-07-22 | 2025-03-11 | 信达生物制药(苏州)有限公司 | 促进多特异性抗体的重链和轻链同源配对的突变体 |
-
2022
- 2022-12-07 CA CA3241912A patent/CA3241912A1/en active Pending
- 2022-12-07 EP EP22903521.7A patent/EP4446341A4/en active Pending
- 2022-12-07 WO PCT/CN2022/137266 patent/WO2023104100A1/zh not_active Ceased
- 2022-12-07 KR KR1020247022135A patent/KR20240136952A/ko active Pending
- 2022-12-07 CN CN202280081161.0A patent/CN118339185A/zh active Pending
- 2022-12-07 JP JP2024533998A patent/JP2025501461A/ja active Pending
- 2022-12-07 US US18/716,203 patent/US20250034268A1/en active Pending
- 2022-12-07 AU AU2022405415A patent/AU2022405415A1/en active Pending